Test Code IGAS IgA Subclasses, Serum
Reporting Name
IgA Subclasses, SUseful For
Investigation of immune deficiency due to IgA2 deficiency
Evaluating patients with anaphylactic transfusion reactions
Method Name
Turbidimetry
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
SerumSpecimen Required
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Â Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Ambient | 7 days | ||
Frozen | 7 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | Reject |
Gross icterus | OK |
Reference Values
IgA
1-3.9 years: 5-194 mg/dL
4-6.9 years: 16-210 mg/dL
7-9.9 years: 27-227 mg/dL
10-11.9 years: 35-241 mg/dL
12-13.9 years: 43-252 mg/dL
14-15.9 years: 50-263 mg/dL
16-17.9 years: 57-274 mg/dL
>18 years: 85-499 mg/dL
IgA1
1-3.9 years: 6-163 mg/dL
4-6.9 years: 16-186 mg/dL
7-9.9 years: 26-209 mg/dL
10-11.9 years: 34-228 mg/dL
12-13.9 years: 40-243 mg/dL
14-15.9 years: 46-259 mg/dL
16-17.9 years: 53-274 mg/dL
>18 years: 76-328 mg/dL
IgA2
1-3.9 years: <0.5-12.4 mg/dL
4-6.9 years: <0.5-25.7 mg/dL
7-9.9 years: 1.5-38.9 mg/dL
10-11.9 years: 2.9-49.9 mg/dL
12-13.9 years: 4.0-58.7 mg/dL
14-15.9 years: 5.2-67.5 mg/dL
16-17.9 years: 6.3-76.3 mg/dL
>18 years: 6.9-114.3 mg/dL
Day(s) Performed
Tuesday, Friday
CPT Code Information
82784
82787 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
IGAS | IgA Subclasses, S | 87552-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
IGA_ | IgA | 2458-8 |
IGA1_ | IgA1 | 6886-6 |
IGA2_ | IgA2 | 6939-3 |
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.Clinical Information
Immunoglobulin A (IgA), the predominant immunoglobulin secreted at mucosal surfaces and the second most abundant immunoglobulin in serum, consists of 2 subclasses, IgA1 and IgA2. These subclasses differ in their molecular structure and tissue distribution. IgA1 is the major (approximately 80%) subclass in serum. It has a longer hinge region making it more susceptible to proteolytic cleavage. IgA2 is the major subclass in secretions such as milk, tears, sweat, and saliva. Although IgA deficiency is a common defect (1 in 700), it is usually asymptomatic. IgA deficiency with or without IgG subclass deficiency, however, can lead to recurrent pulmonary and gastrointestinal infections. In selective IgA deficiency, both IgA1 and IgA2 are deficient. It is also possible that only one of the subclasses is deficient. Some infections (eg, recurrent sinopulmonary infections with Haemophilus influenzae) may be related to a deficiency of IgA2, even in the presence of normal total IgA concentrations.
Paradoxically, bacterial infections may also cause IgA deficiency. IgA2 is more resistant to bacterial destruction than IgA1. Certain bacteria can cleave and inactivate IgA1, but not IgA2, thus depleting most of the IgA. In the presence of a concurrent IgA2 deficiency, infection by these organisms results in an apparent IgA deficiency.
IgA deficiency is a cause of anaphylactic transfusion reactions. In these situations, patients who are IgA deficient produce anti-IgA antibodies that react with IgA present in the transfusion product. While transfusion reactions typically occur in patients who have no detectable concentrations of IgA, they can also occur in patients with measurable IgA. In these situations, the complete deficiency of 1 of the IgA subclasses may be the cause of the transfusion reactions.
Interpretation
Low concentrations of IgA2 with normal amounts of IgA1 suggest an IgA2 deficiency.
Elevated concentrations of IgA2 with normal or low amounts of IgA1 suggest a clonal plasma cell proliferative disorder secreting a monoclonal IgA2.
Increased total IgA concentrations may also be seen in benign disorders (eg, infection, inflammation, allergy), hyper IgD syndrome with periodic fever, and monoclonal gammopathies (eg, myeloma, monoclonal gammopathies of undetermined significance [MGUS]).
Method Description
The determination of soluble antigen concentration by turbidimetric methods involves the reaction with specific antiserum to form insoluble complexes. When light is passed through the suspension formed, a portion of the light is transmitted and focused onto a photodiode by an optical lens system. The amount of transmitted light is indirectly proportional to the specific protein concentration in the test sample. Concentrations are automatically calculated by reference to a calibration curve stored within the instrument.(Package inserts: Optilite IgA Kit. The Binding Site Group, Ltd; ver 5, 08/2015; Optilite IgA1. The Binding Site Group, Ltd; ver 19, 04/2016; Optilite IgA2. The Binding Site Group, Ltd; ver 11, 02/2015)
Report Available
Same day/1 to 3 daysSpecimen Retention Time
14 daysCautions
Quantitation of specific proteins by nephelometric means may not be possible in lipemic sera due to the extreme light scattering properties of the specimen. Turbidity and particles in the specimen may result in extraneous light scattering signals, resulting in variable specimen analysis.